Tags:BioTechITLifeManufacturingOwnPharmacyProduct
Asarina Pharma is developing novel and targeted products to treat women with severe symptoms associated with the menstrual cycle such as premenstrual dysphoric disorder (PMDD), allowing these women to remain in control of their own life.
Likes
469
Location: Sweden, Botkyrka kommun
Member count: 1-10
Total raised: $7.731816M
Founded date: 2006

Investors 2

Funding Rounds 1

DateSeriesAmountInvestorsDeal News
07.11.2016-$7.731816M-finsmes.co...

Mentions in press and media 16

DateTitleDescriptionCategoryAuthorSource
05.09.2022Asarina Ph...Asarina Pharma AB: new US CDC ...--news.cisio...
25.08.2022Asarina Ph...Asarina Pharma AB (publ) Q2 20...--news.cisio...
25.05.2022Asarina Ph...Asarina Pharma AB (publ) Q1 20...--news.cisio...
06.04.2022ASARINA PH...ASARINA PHARMA AB (publ) ANNUA...--news.cisio...
24.02.2022Asarina Ph...Asarina Pharma AB (publ) Year-...--news.cisio...
16.02.2022First pati...First patient in for landmark ...--news.cisio...
22.12.2021Asarina Ph...Asarina Pharma receives final ...--news.cisio...
25.11.2021Asarina Ph...Asarina Pharma AB (publ) Q3 Re...--news.cisio...
28.09.2021PMDD Phase...PMDD Phase IIb study, includin...--news.cisio...
16.09.2021Administra...Administrative backlog at publ...--news.cisio...
Show more